Related Experiment Video

Updated: Jul 4, 2025

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
00:04

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

10.7K

Power Considerations in Designing and Interpreting Adaptive Clinical Trials

Rui Wang1,2, Cyrus Mehta2,3

  • 1Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston.

NEJM Evidence
|February 6, 2024
PubMed

Insights

Adaptive clinical trials enable real-time study modifications. The Apixaban for Treatment of Embolic Stroke of Undetermined Source (ATTICUS) trial evaluated apixaban versus aspirin in patients with cardioembolism risk factors.

Area of Science:

  • Clinical Trials
  • Cardiovascular Research
  • Neurology

Background:

  • Adaptive clinical trials offer flexibility in study design by allowing pre-planned modifications based on interim data.
  • These modifications can optimize trial efficiency and validity, including sample size adjustments and treatment alterations.
  • The Apixaban for Treatment of Embolic Stroke of Undetermined Source (ATTICUS) trial investigated apixaban against aspirin in patients with cardioembolism risk factors.

Discussion:

  • The ATTICUS trial's adaptive design allowed for data-driven adjustments, potentially enhancing the precision and relevance of the findings.
  • Evaluating novel anticoagulants like apixaban is crucial for managing stroke risk in patients with cardioembolic sources.
  • Comparing apixaban with aspirin provides insights into optimal secondary stroke prevention strategies.

Key Insights:

  • The study reports on the comparative efficacy and safety of apixaban versus aspirin in a specific stroke population.
  • Results from the ATTICUS trial contribute to the evidence base for antithrombotic therapy in stroke of undetermined source.
  • Findings may inform clinical guidelines regarding the use of direct oral anticoagulants in secondary stroke prevention.

Outlook:

  • Future research may explore long-term outcomes and cost-effectiveness of apixaban in this patient group.
  • The application of adaptive trial methodologies in cardiovascular research is expected to grow.
  • Continued investigation into personalized antithrombotic strategies based on individual patient risk profiles is warranted.

More Related Videos

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.5K
A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting14:43

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting

Published on: January 12, 2018

11.8K

Related Concept Videos

Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
6.7K
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.9K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
128
Blinding01:11

Blinding

Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
2.5K
Preclinical Development: Overview01:28

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.4K
Crossover Experiments01:16

Crossover Experiments

Crossover experiments, also called the repeated-measurements design, is a study design in which all experimental units are exposed to all treatments in different periods. Crossover experiments are generally used in psychology, the pharmaceutical industry, agriculture, and medicine.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
2.8K